Article
Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy.
Journal of experimental & clinical cancer research : CR - 1 Nov 2019
Silkenstedt Elisabeth, Arenas Fabian, Colom-Sanmartí Berta, Xargay-Torrent Sílvia, Higashi Morihiro, Giró Ariadna, Rodriguez Vanina, Fuentes Patricia, Aulitzky Walter E, van der Kuip Heiko, Beà Sílvia, Toribio Maria L, Campo Elias, López-Guerra Mònica, Colomer Dolors
Abstract excerpt
BACKGROUND: NOTCH1 gene mutations in mantle cell lymphoma (MCL) have been described in about 5-10% of cases and are associated with significantly shorter survival rates. The present study aimed to investigate the biological impact of this mutation in MCL and its potential as a therapeutic target. METHODS: Activation of Notch1 signaling upon ligand-stimulation and inhibitory effects of the monoclonal anti-Notch1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
